+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Monkeypox Testing Market Outlook 2026-2034: by Test Type (PCR, Lateral Flow Assay / Rapid Antigen, Serology / Antibody ELISA, Other Test Types), Sample Type, End User

  • PDF Icon

    Report

  • 160 Pages
  • October 2026
  • Region: Global
  • OG Analysis
  • ID: 6243050
UP TO OFF until Jan 01st 2027
The Monkeypox Testing Market is estimated at US$2 billion in 2026 and is projected to grow at a CAGR of 5.2% to reach US$3 billion by 2034.

Market Overview

The Monkeypox Testing Market covers diagnostic assays, laboratory services, and sample processing workflows used to detect monkeypox infection and support case confirmation, surveillance, and outbreak response.

Relevant uses and settings include public health laboratories, hospital diagnostics, outbreak screening, reference testing, and emergency infectious disease preparedness programs. Commercial considerations include volatile demand, stock management risk, regulatory adaptation, and uncertainty over sustained investment outside active outbreak periods.

Market Segmentation

By Test Type

  • PCR
  • Lateral Flow Assay / Rapid Antigen
  • Serology / Antibody ELISA
  • Other Test Types

By Sample Type

  • Lesion Swab / Exudate
  • Scab / Crust
  • Blood / Serum
  • Oropharyngeal / Nasopharyngeal Swab

By End User

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Public-Health / Reference Labs
  • Research & Academic Institutes
  • Home & Community POC Settings

Key Companies Analysed

  • Roche
  • Thermo Fisher Scientific
  • QIAGEN
  • Seegene
  • bioMérieux
  • Becton Dickinson
  • CerTest Biotec
  • Genes2Me
  • Sansure Biotech
  • Aptitude Medical Systems
  • Abbott
  • Bio-Rad Laboratories
  • Hologic
  • DiaSorin
  • F. Hoffmann-La Roche
  • Luminex
  • TIB Molbiol
  • SD Biosensor
  • Trivitron Healthcare
  • Bioneer

Geographic Coverage

  • North America - Market data and outlook to 2034
    • United States
    • Canada
    • Mexico

  • Europe - Market data and outlook to 2034
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Netherlands
    • Switzerland
    • Poland
    • Sweden
    • Russia

  • Asia-Pacific - Market data and outlook to 2034
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Vietnam

  • Middle East and Africa - Market data and outlook to 2034
    • Saudi Arabia
    • South Africa
    • Iran
    • UAE
    • Egypt

  • South and Central America - Market data and outlook to 2034
    • Brazil
    • Argentina
    • Chile
    • Peru

*We can include data and analysis of additional countries on demand.

Report Delivery and Support

  • Updated PDF report and an MS Excel workbook containing market tables and figures.
  • 7-day post-sale analyst support for clarifications and in-scope supplementary data.
  • Complimentary report update covering the latest available data and relevant market developments.

This product will be delivered within 1-3 business days.

Table of Contents

1. Contents and Report Guide
1.1. List of Tables
1.2. List of Figures
2. Global Monkeypox Testing Market Overview
2.1. Monkeypox Testing Market Scope and Definitions
2.2. Research Methodology and Forecast Assumptions
2.3. Value Chain and Relevant Adjacent Markets
3. Monkeypox Testing Market Dynamics
3.1. Demand Drivers
3.2. Constraints and Adoption Barriers
3.3. Technology and Commercial Trends
3.4. Regulatory and Supply-Chain Considerations
4. Monkeypox Testing Market Strategic Analysis
4.1. Competitive Structure
4.2. Pricing and Purchasing Factors
4.3. Customer Requirements and Opportunity Assessment
5. Global Monkeypox Testing Market Size, Share and Forecast, 2025-2034
5.1. Revenue Outlook, 2025-2034 (US$ billion)
5.2. Monkeypox Testing Market Analysis By Test Type, 2025-2034
5.2.1. PCR
5.2.2. Lateral Flow Assay / Rapid Antigen
5.2.3. Serology / Antibody ELISA
5.2.4. Other Test Types
5.3. Monkeypox Testing Market Analysis By Sample Type, 2025-2034
5.3.1. Lesion Swab / Exudate
5.3.2. Scab / Crust
5.3.3. Blood / Serum
5.3.4. Oropharyngeal / Nasopharyngeal Swab
5.4. Monkeypox Testing Market Analysis By End User, 2025-2034
5.4.1. Hospitals & Clinics
5.4.2. Diagnostic Laboratories
5.4.3. Public-Health / Reference Labs
5.4.4. Research & Academic Institutes
5.4.5. Home & Community POC Settings
6. North America Monkeypox Testing Market Outlook to 2034
6.1. North America Market Snapshot
6.2. North America Monkeypox Testing Market Analysis By Test Type
6.3. North America Monkeypox Testing Market Analysis By Sample Type
6.4. North America Monkeypox Testing Market Analysis By End User
6.5. North America Outlook By Country
6.5.1. United States
6.5.2. Canada
6.5.3. Mexico
7. Europe Monkeypox Testing Market Outlook to 2034
7.1. Europe Market Snapshot
7.2. Europe Monkeypox Testing Market Analysis By Test Type
7.3. Europe Monkeypox Testing Market Analysis By Sample Type
7.4. Europe Monkeypox Testing Market Analysis By End User
7.5. Europe Outlook By Country
7.5.1. Germany
7.5.2. United Kingdom
7.5.3. France
7.5.4. Italy
7.5.5. Spain
7.5.6. Netherlands
7.5.7. Switzerland
7.5.8. Poland
7.5.9. Sweden
7.5.10. Russia
8. Asia-Pacific Monkeypox Testing Market Outlook to 2034
8.1. Asia-Pacific Market Snapshot
8.2. Asia-Pacific Monkeypox Testing Market Analysis By Test Type
8.3. Asia-Pacific Monkeypox Testing Market Analysis By Sample Type
8.4. Asia-Pacific Monkeypox Testing Market Analysis By End User
8.5. Asia-Pacific Outlook By Country
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia
8.5.6. Indonesia
8.5.7. Malaysia
8.5.8. Vietnam
9. Middle East and Africa Monkeypox Testing Market Outlook to 2034
9.1. Middle East and Africa Market Snapshot
9.2. Middle East and Africa Monkeypox Testing Market Analysis By Test Type
9.3. Middle East and Africa Monkeypox Testing Market Analysis By Sample Type
9.4. Middle East and Africa Monkeypox Testing Market Analysis By End User
9.5. Middle East and Africa Outlook By Country
9.5.1. Saudi Arabia
9.5.2. South Africa
9.5.3. Iran
9.5.4. United Arab Emirates
9.5.5. Egypt
10. South and Central America Monkeypox Testing Market Outlook to 2034
10.1. South and Central America Market Snapshot
10.2. South and Central America Monkeypox Testing Market Analysis By Test Type
10.3. South and Central America Monkeypox Testing Market Analysis By Sample Type
10.4. South and Central America Monkeypox Testing Market Analysis By End User
10.5. South and Central America Outlook By Country
10.5.1. Brazil
10.5.2. Argentina
10.5.3. Chile
10.5.4. Peru
11. Monkeypox Testing Market Competitive Landscape
11.1. Market Participants and Strategic Positioning
11.2. Company Profiles: Product Portfolios, Positioning and Strategies
11.2.1. Roche
11.2.2. Thermo Fisher Scientific
11.2.3. QIAGEN
11.2.4. Seegene
11.2.5. bioMérieux
11.2.6. Becton Dickinson
11.2.7. CerTest Biotec
11.2.8. Genes2Me
11.2.9. Sansure Biotech
11.2.10. Aptitude Medical Systems
11.2.11. Abbott
11.2.12. Bio-Rad Laboratories
11.2.13. Hologic
11.2.14. DiaSorin
11.2.15. F. Hoffmann-La Roche
11.2.16. Luminex
11.2.17. TIB Molbiol
11.2.18. SD Biosensor
11.2.19. Trivitron Healthcare
11.2.20. Bioneer
12. Appendix
12.1. Definitions and Abbreviations
12.2. Data Sources and Methodology
12.3. Publisher Information

Companies Mentioned

  • Roche
  • Thermo Fisher Scientific
  • QIAGEN
  • Seegene
  • bioMérieux
  • Becton Dickinson
  • CerTest Biotec
  • Genes2Me
  • Sansure Biotech
  • Aptitude Medical Systems
  • Abbott
  • Bio-Rad Laboratories
  • Hologic
  • DiaSorin
  • F. Hoffmann-La Roche
  • Luminex
  • TIB Molbiol
  • SD Biosensor
  • Trivitron Healthcare
  • Bioneer

Table Information